Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.
Also called NCT07275697
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT07275697 -
2025-524182-25-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Sweden
- Registry status
- Recruiting
Technical summary
Registry record NCT07275697. Randomized; single masking; primary purpose treatment. Start 2026-03-23 (actual); primary completion 2028-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study
- Acronym
- WAIT
- Condition
- Atrial Fibrillation (AF)
- Condition
- Obesity & Overweight
- Intervention (Drug)
- Semaglutide 2.4 mg
- Intervention (Behavioral)
- Standard medical treatment
- Lead sponsor
- Emma Svennberg
- Collaborator
- Karolinska Institutet
Record details
- Record id
cardio:ct-nct07275697- Content hash
827053bb32afb80e743a24f19bc1469d31b31dc58a943afdc1cc28a372ef7451